A. Misino

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

Giuseppe Colucci, Vittorio Gebbia, G Paoletti et al. · Journal of Clinical Oncology · 2005 · 781 citations

Medicine, Oncology, Pharmacotherapy +11

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 93 citations · Full text

Medicine, Oncology, Pharmacology +13

VEGF concentration from plasma‐activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model

Rosa Patruno, Nicola Arpaia, Cosmo Damiano Gadaleta et al. · Journal of Cellular and Molecular Medicine · 2008 · 80 citations · Full text

Medicine, Oncology, Veterinary Pathology +14

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial

Domenico Galetta, Saverio Cinieri, Salvatore Pisconti et al. · Clinical Lung Cancer · 2014 · 78 citations · Full text

Medicine, Oncology, Pharmacology +14

Epithelial ovarian cancer: Second and third line chemotherapy (Review)

Agnese Latorre, M. De Lena, Annamaria Catino et al. · International Journal of Oncology · 2002 · 36 citations

Medicine, Oncology, Pharmacology +15